Development of Novel Cardiovascular Therapeutics From Small Regulatory RNA Molecules - An Outline of Key Requirements

E-ISSN： 1873-4286|16|20|2252-2268

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.20, 2010-07, pp. : 2252-2268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemical modification of nucleic acids as a key technology for the development of RNA-based therapeutics

By Grünweller A. Hartmann R. K.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 71, Iss. 1, 2016-01 ,pp. : 8-16

Govi-Verlag

Access to resources Recommend Favorite

miRNA: Small Molecules as Potential Novel Biomarkers in Cancer

Current Medicinal Chemistry, Vol. 17, Iss. 36, 2010-12 ,pp. : 4427-4432

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Inflammatory Biomarkers in Cardiovascular Therapeutics

Current Medicinal Chemistry, Vol. 22, Iss. 23, 2015-01 ,pp. : 2773-2785

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting RNA with Small Molecules

Current Medicinal Chemistry, Vol. 7, Iss. 1, 2000-01 ,pp. : 73-98

Bentham Science Publishers

Access to resources Recommend Favorite

RNA as a target for small-molecule therapeutics

By Hermann Thomas Tor Yitzhak

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 1, 2005-01 ,pp. : 49-62

Informa Healthcare

Access to resources Recommend Favorite